IL2 and neoplasm: Flow cytometry analysis on re-stimulated splenocytes, showed that mice treated with CBL0137 had significantly higher numbers of tumor-specific T cells, as shown by the higher percentages of T cells expressing IL-2, IFNγ or TNFα, particularly in the CD4+ T cell compartment (Fig. 4D).